Seguimiento posterior a la cirugía metabólica

1 The Look AHEAD Research Group. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomized clinical trial. Lancet Diabetes Endocrinol 2016; 4: 913–21.

2 Angrisani L, Santonicola A, Iovino P, Formisano G, Buchwald H, Scopinaro N. Bariatric surgery worldwide 2013. Obes Surg 2015; 25: 1822–32.

3 Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg 2017; 27: 2279–89.

4 Sjostrom L, Narbro K, Sjostrom CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741–52.

5 Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007; 357: 753–61.

6 Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683–93.

7 Funk LM, Jolles S, Fischer LE, Voils CI. Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery: a systematic review. JAMA Surg 2015; 150: 999–1005.

8 Schiavon CA, Bersch-Ferreria AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation 2017; published online Nov 13. DOI:10.1161/CIRCULATIONAHA.117.032130.

9 Chakhtoura MT, Nakhoul N, Akl EA, Mantzoros CS, El Hajj Fuleihan GA. Guidelines on vitamin D replacement in bariatric surgery: identification and systematic appraisal. Metabolism 2016; 65: 586–97.

10 Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003–2012. JAMA Surg 2014; 149: 275–87.

11 Eisenberg D, Azagury DE, Ghiassi S, Grover BT, Kim JJ. ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery. Surg Obes Relat Dis 2017; 13: 371–78.

12 Bolckmans R, Himpens J. Long-term (>10 yrs) outcome of the laparoscopic biliopancreatic diversion with duodenal switch. Ann Surg 2016; 264: 1029–37.

13 Rebecchi F, Allaix ME, Ugliono E, Giaccone C, Toppino M, Morino M. Increased esophageal exposure to weakly acidic reflux 5 years after laparoscopic-en-Y gastric bypass. Ann Surg 2016; 264: 871–77.

14 Greenstein AJ, O’Rourke RW. Abdominal pain after gastric bypass: suspects and solutions. Am J Surg 2011; 201: 819–27.

15 Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567–76.

16 Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes. N Engl J Med 2014; 370: 2002–13.

17 Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes. N Engl J Med 2017; 376: 641–51.

18 Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577–85.

19 Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single centre, randomised controlled trial. Lancet 2015; 386: 964–73.

20 Ikramuddin S, Korner J, Lee WJ, et al. En Y de Roux gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013; 309: 2240–49.

21 Ikramuddin S, Billington CJ, Lee W-J, et al. En Y de Roux gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial. Lancet Diabetes Endocrinol 2015; 3: 413–22.

22 Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 2014; 149: 707–15.

23 Suarez Llanos JP, Fuentes Ferrer M, Alvarez-Sala-Walther L, et al. Protein malnutrition incidence comparison after gastric bypass versus biliopancreatic diversion. Nutr Hosp 2015; 32: 80–86.

24 Billeter AT, Probst P, Fischer L, et al. Risk of malnutrition, trace metal, and vitamin deficiency post En Y de Roux gastric bypass—a prospective study of 20 patients with BMI < 35 kg/m2. Obes Surg 2015; 25: 2125–34.

25 Gletsu-Miller N, Wright BN. Mineral malnutrition following bariatric surgery. Adv Nutr 2013; 4: 506–17.

26 Hassn A, Luhmann A, Rahmani S, Morris-Stiff G. Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery. Obes Surg 2016; 26: 2316–23.

27 Salle A, Demarsy D, Poirier AL, et al. Zinc deficiency: a frequent and underestimated complication after bariatric surgery. Obes Surg 2010; 20: 1660–70.

28 Livingstone C. Zinc: physiology, deficiency, and parenteral nutrition. Nutr Clin Pract 2015; 30: 371–82.

29 Muir A, Hopfer U. Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice. Am J Physiol 1985; 248: G376–79.

30 Ruz M, Carrasco F, Rojas P, et al. Heme- and nonheme-iron absorption and iron status 12 mo after sleeve gastrectomy and Roux en- Y gastric bypass in morbidly obese women. Am J Clin Nutr 2012; 96: 810–17.

31 Jauregui-Lobera I. Iron deficiency and bariatric surgery. Nutrients 2013; 5: 1595–608.

32 Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ 2013; 347: f5934.

33 Stroh C, Meyer F, Manger T. Beriberi, a severe complication after metabolic surgery—review of the literature. Obes Facts 2014; 7: 246–52.

34 Visentin M, Diop-Bove N, Zhao R, Goldman ID. The intestinal absorption of folates. Annu Rev Physiol 2014; 76: 251–74.

35 Herzlich B, Herbert V. The role of the pancreas in cobalamin (vitamin B12) absorption. Am J Gastroenterol 1984; 79: 489–93.

36 Pelizzo G, Nakib G, Alfei A, et al. Fetal neural tube defects in pregnant women previously submitted to bariatric surgery: more attention to a new emerging entity. Prenat Diagn 2013; 33: 196–97.

37 Eerdekens A, Debeer A, Van Hoey G, et al. Maternal bariatric surgery: adverse outcomes in neonates. Eur J Pediatr 2010; 169: 191–96.

38 Maislos M, Shany S. Bile salt deficiency and the absorption of vitamin D metabolites. In vivo study in the rat. Isr J Med Sci 1987; 23: 1114–17.

39 Pellitero S, Martinez E, Puig R, et al. Evaluation of vitamin and trace element requirements after sleeve gastrectomy at long term. Obes Surg 2017; 27: 1674–82.

40 Cole AJ, Beckman LM, Earthman CP. Vitamin D status following bariatric surgery: implications and recommendations. Nutr Clin Pract 2014; 29: 751–58.

41 Schafer AL. Vitamin D and intestinal calcium transport after bariatric surgery. J Steroid Biochem Mol Biol 2017; 173: 202–10.

42 Balsa JA, Botella-Carretero JI, Peromingo R, et al. Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density. Obes Surg 2010; 20: 468–73.

43 Jans G, Matthys C, Bogaerts A, et al. Maternal micronutrient deficiencies and related adverse neonatal outcomes after bariatric surgery: a systematic review. Adv Nutr 2015; 6: 420–29.

44 Van Mieghem T, Van Schoubroeck D, Depiere M, Debeer A, Hanssens M. Fetal cerebral hemorrhage caused by vitamin K deficiency after complicated bariatric surgery. Obstet Gynecol 2008; 112: 434–36.

45 Shanbhogue VV, Stoving RK, Frederiksen KH, et al. Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study. Eur J Endocrinol 2017; 176: 685–93.

46 Nakamura KM, Haglind EG, Clowes JA, et al. Fracture risk following bariatric surgery: a population-based study. Osteoporos Int 2014; 25: 151–58.

47 Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ 2016; 354: i3794.

48 Lalmohamed A, de Vries F, Bazelier MT, et al. Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study. BMJ 2012; 345: e5085.

49 van Beek AP, Emous M, Laville M, Tack J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev 2017; 18: 68–85.

50 Nannipieri M, Belligoli A, Guarino D, et al. Risk factors for spontaneously self-reported postprandial hypoglycemia after bariatric surgery. J Clin Endocrinol Metab 2016; 101: 3600–07.

51 Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC. Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis 2013; 9: 26–31.

52 Papamargaritis D, Koukoulis G, Sioka E, et al. Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy. Obes Surg 2012; 22: 1600–06.

53 Mala T. Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment. Surg Obes Relat Dis 2014; 10: 1220–25.

54 Lieske JC, Mehta RA, Milliner DS, Rule AD, Bergstralh EJ, Sarr MG. Kidney stones are common after bariatric surgery. Kidney Int 2015; 87: 839–45.

55 Moreland AM, Santa Ana CA, Asplin JR, et al. Steatorrhea and hyperoxaluria in severely obese patients before and after En Y de Roux gastric bypass. Gastroenterology 2017; 152: 1055–67.

56 Thongprayoon C, Cheungpasitporn W, Vijayvargiya P, Anthanont P, Erickson SB. The risk of kidney stones following bariatric surgery: a systematic review and meta-analysis. Ren Fail 2016; 38: 424–30.